Skip to main
THC
THC logo

Tenet Healthcare (THC) Stock Forecast & Price Target

Tenet Healthcare (THC) Analyst Ratings

Based on 32 analyst ratings
Buy
Strong Buy 34%
Buy 44%
Hold 22%
Sell 0%
Strong Sell 0%

Bulls say

Tenet Healthcare has demonstrated strong financial performance, highlighted by an impressive +19.3% year-over-year growth in same-facility ambulatory surgery center (ASC) total joints and a solid +21.0% year-over-year revenue increase in the ambulatory segment, amounting to $1.14 billion. The company's focus on higher margin volume has resulted in a commendable 3.3% growth in revenue per adjusted admission for its hospital segment, indicating effective capacity expansion and service line enhancements. Management anticipates sustained demand and growth, driven by pricing strategies, operational efficiencies, and beneficial partnerships, positioning Tenet for continued financial success.

Bears say

Tenet Healthcare faces significant headwinds, with projected EBITDA expected to be 5% lower than estimates due to higher than anticipated professional fees and labor costs, alongside revenue expectations slipping to a range of $5.007 billion to $5.207 billion as a result of recent hospital divestitures. The company’s EBITDA leverage ratio is also concerning, decreasing from 5.6x in 2018 to 2.5x in 2024, indicating increasing financial strain. Additionally, ongoing reimbursement risks, geographic concentration, and a leveraged balance sheet contribute to a wary outlook on the company's operational stability and growth prospects in the context of potential economic downturn and policy uncertainty.

Tenet Healthcare (THC) has been analyzed by 32 analysts, with a consensus rating of Buy. 34% of analysts recommend a Strong Buy, 44% recommend Buy, 22% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Tenet Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Tenet Healthcare (THC) Forecast

Analysts have given Tenet Healthcare (THC) a Buy based on their latest research and market trends.

According to 32 analysts, Tenet Healthcare (THC) has a Buy consensus rating as of Jul 1, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $125.84, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $125.84, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Tenet Healthcare (THC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.